Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, November 3, 2014
[ Mon, Nov 03rd 2014
] - WOPRAI
[ Mon, Nov 03rd 2014
] - WOPRAI
[ Mon, Nov 03rd 2014
] - WOPRAI
[ Mon, Nov 03rd 2014
] - WOPRAI
[ Mon, Nov 03rd 2014
] - WOPRAI
[ Mon, Nov 03rd 2014
] - WOPRAI
[ Mon, Nov 03rd 2014
] - WOPRAI
Fri, October 31, 2014
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
[ Fri, Oct 31st 2014
] - WOPRAI
David Risinger Maintained (TEVA) at Hold with Increased Target to $61 on, Oct 31st, 2014
David Risinger of Morgan Stanley, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $57 to $61 on, Oct 31st, 2014.
David has made no other calls on TEVA in the last 4 months.
There is 1 other peer that has a rating on TEVA. Out of the 1 peers that are also analyzing TEVA, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Chris Schott of "JP Morgan" Maintained at Hold with Increased Target to $58 on, Monday, July 28th, 2014
Similar Stocks and Investing Articles
[ Mon, Jul 28th 2014
] - WOPRAI
[ Tue, Jun 10th 2014
] - WOPRAI
[ Fri, Apr 04th 2014
] - WOPRAI
[ Tue, Apr 01st 2014
] - WOPRAI
[ Fri, Mar 28th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
[ Fri, Mar 14th 2014
] - WOPRAI
[ Mon, Mar 03rd 2014
] - WOPRAI
[ Tue, Jan 28th 2014
] - WOPRAI